Expert consensus on diagnosis and treatment of end-stage liver disease complicated with infections.
10.3760/cma.j.issn.1007-3418.2018.08.003
- Collective Name:Chinese Society of Infectious Diseases, Chinese Medical Association
- Publication Type:Journal Article
- Keywords:
Consensus;
Diagnosis;
End stage of liver disease;
Infection;
Therapy
- MeSH:
Bacterial Infections/complications*;
Coinfection;
Consensus;
Disease Progression;
End Stage Liver Disease/therapy*;
Humans;
Liver Transplantation
- From:
Chinese Journal of Hepatology
2018;26(8):568-578
- CountryChina
- Language:Chinese
-
Abstract:
End-stage liver disease (ESLD) is a life threaten clinical syndrome with significantly increasing mortality when patients complicated with infections. For patients with ESLD, infections can induce or aggravate the occurrence of liver decompensation. In turn, infections are among the most common complications under, disease progression. There is lacking of working procedures for early diagnosis and appropriate management for patients of ESLD complicated with infections, neither guidelines nor consensus at home and abroad. This consensus assembled up-to-date knowledge and experience across Chinese colleagues, providing principles as well as working procedures for clinicians to diagnose and treat an ESLD patient complicated with infections.
